For Sale : Order MS CONTIN (MORPHINE SULFATE) 100 MG ORAL TABLET- POWERALL EMPORIUM

Posted on March 04, 2022 12:48 am - All Ads by this Poster - Email to friend - Flag this Ad

Details:

Price
(Negotiable)
Location
Toronto,
View Map
Phone
303-500-7662

Description:

MS CONTIN (morphine sulfate extended-release tablets) is for oral use and contains morphine sulfate, an opioid agonist.

Each tablet contains the following inactive ingredients common to all strengths: cetostearyl alcohol, hydroxyethyl cellulose, hypromellose, magnesium stearate, polyethylene glycol, talc and titanium dioxide.

The tablet strengths describe the amount of morphine per tablet as the pentahydrated sulfate salt (morphine sulfate).

Morphine sulfate is an odorless, white, crystalline powder with a bitter taste. It has a solubility of 1 in 21 parts of water and 1 in 1 parts of alcohol, but is practically insoluble in chloroform or ether. The octanol: water partition coefficient of morphine is 1.42 at physiologic pH and the pK is 7.9 for the tertiary nitrogen (mostly ionized at pH 7.4). Its molecular weight is 758.83

INDICATIONS
MS CONTIN is indicated for the management of pain severe enough to require daily, around-the clock, long-term opioid treatment and for which alternative treatment options are inadequate.

Dosage Forms And Strengths:
MS CONTINĀ® (morphine sulfate extended-release tablets) 1 mg* Round, gray-colored, film-coated tablets bearing the symbol PF on one side and 1 on the other

Storage And Handling:
MS CONTINĀ® (morphine sulfate extended-release tablets) 1 mg are round, gray-colored, film coated tablets bearing the symbol PF on one side and 1 on the other

For More Info
https://www.powerallemporium.org/shop/medications/prescription-drugs/ms-contin-morphine-sulfate-100-mg-oral-tablet/
Text: +1(303) 500-7662
Email: sales@powerallemporium.org

Safety Warning

Users are recommended to deal face-to-face and avoid distant users. eClassifieds4U does not offer any payment/transaction services.

Read more about Safety Tips.


Reply to this Ad
Enter the characters shown in image:

By clicking on 'Send Reply', you have read & agree to our TOS & Privacy Policy.


Report this Ad
Report the Ad with Care